Without making public the documents related to the authorisation of the Russian Sputnik-V and Chinese Sinopharm vaccines – especially the summary of product characteristics – the leadership of the Hungarian Medical Chamber “cannot recommend the use of these products to its colleagues in good conscience,” the doctors wrote to the Hungarian National Institute of Pharmacy and Food and Health (OGYÉI) on Tuesday.
The Hungarian authority recently granted limited marketing authorisation to both the Russian and Chinese jabs in record time.
Faced with severe delays of other approved vaccines’ deliveries, the EU has left the door open to make use of Chinese and Russian vaccines to speed up vaccination of the EU population.
“If the Russian producers, the Chinese producers open their books, show transparency, show all the data… then they could get… a conditional market authorisation like the other ones,” EU Commission chief Ursula von der Leyen told MEPs at a meeting, AFP reported.
But Hungarian medical professionals complained that the authorising authority has not made this paperwork public, since “product characteristics is the basic condition for the use of a product to guarantee patient safety, establishing the legal and ethical protections of the doctor.”
“No documents can be found on the OGYÉI website regarding the use of these vaccines,” the medical professionals added.
(Vlagyiszlav Makszimov | EURACTIV.com)